349 related articles for article (PubMed ID: 36865541)
1. Regulation of innate immune signaling by IRAK proteins.
Pereira M; Gazzinelli RT
Front Immunol; 2023; 14():1133354. PubMed ID: 36865541
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 receptor-associated kinase 4 (IRAK4) plays a dual role in myddosome formation and Toll-like receptor signaling.
De Nardo D; Balka KR; Cardona Gloria Y; Rao VR; Latz E; Masters SL
J Biol Chem; 2018 Sep; 293(39):15195-15207. PubMed ID: 30076215
[TBL] [Abstract][Full Text] [Related]
3. IRAK-4 as the central TIR signaling mediator in innate immunity.
Suzuki N; Suzuki S; Yeh WC
Trends Immunol; 2002 Oct; 23(10):503-6. PubMed ID: 12297423
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4.
Burns K; Janssens S; Brissoni B; Olivos N; Beyaert R; Tschopp J
J Exp Med; 2003 Jan; 197(2):263-8. PubMed ID: 12538665
[TBL] [Abstract][Full Text] [Related]
5. The IRAK4 scaffold integrates TLR4-driven TRIF and MYD88 signaling pathways.
Pereira M; Durso DF; Bryant CE; Kurt-Jones EA; Silverman N; Golenbock DT; Gazzinelli RT
Cell Rep; 2022 Aug; 40(7):111225. PubMed ID: 35977521
[TBL] [Abstract][Full Text] [Related]
6. Regulations and roles of the interleukin-1 receptor associated kinases (IRAKs) in innate and adaptive immunity.
Gan L; Li L
Immunol Res; 2006; 35(3):295-302. PubMed ID: 17172653
[TBL] [Abstract][Full Text] [Related]
7. IRAK-M is a negative regulator of Toll-like receptor signaling.
Kobayashi K; Hernandez LD; Galán JE; Janeway CA; Medzhitov R; Flavell RA
Cell; 2002 Jul; 110(2):191-202. PubMed ID: 12150927
[TBL] [Abstract][Full Text] [Related]
8. Visualization of Myddosome Assembly in Live Cells.
Cao F; Taylor MJ
Methods Mol Biol; 2023; 2654():231-250. PubMed ID: 37106186
[TBL] [Abstract][Full Text] [Related]
9. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
[TBL] [Abstract][Full Text] [Related]
10. Understanding early TLR signaling through the Myddosome.
Balka KR; De Nardo D
J Leukoc Biol; 2019 Feb; 105(2):339-351. PubMed ID: 30256449
[TBL] [Abstract][Full Text] [Related]
11. The interleukin-1 receptor-associated kinases: critical regulators of innate immune signalling.
Flannery S; Bowie AG
Biochem Pharmacol; 2010 Dec; 80(12):1981-91. PubMed ID: 20599782
[TBL] [Abstract][Full Text] [Related]
12. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family.
Martin MU; Wesche H
Biochim Biophys Acta; 2002 Nov; 1592(3):265-80. PubMed ID: 12421671
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of human IRAK1.
Wang L; Qiao Q; Ferrao R; Shen C; Hatcher JM; Buhrlage SJ; Gray NS; Wu H
Proc Natl Acad Sci U S A; 2017 Dec; 114(51):13507-13512. PubMed ID: 29208712
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
Cui J; Chen Y; Wang HY; Wang RF
Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
[TBL] [Abstract][Full Text] [Related]
15. Inherited human IRAK-1 deficiency selectively impairs TLR signaling in fibroblasts.
Della Mina E; Borghesi A; Zhou H; Bougarn S; Boughorbel S; Israel L; Meloni I; Chrabieh M; Ling Y; Itan Y; Renieri A; Mazzucchelli I; Basso S; Pavone P; Falsaperla R; Ciccone R; Cerbo RM; Stronati M; Picard C; Zuffardi O; Abel L; Chaussabel D; Marr N; Li X; Casanova JL; Puel A
Proc Natl Acad Sci U S A; 2017 Jan; 114(4):E514-E523. PubMed ID: 28069966
[TBL] [Abstract][Full Text] [Related]
16. Lack of IL-1 Receptor-Associated Kinase-4 Leads to Defective Th1 Cell Responses and Renders Mice Susceptible to Mycobacterial Infection.
Marinho FV; Fahel JS; Scanga CA; Gomes MT; Guimarães G; Carvalho GR; Morales SV; Báfica A; Oliveira SC
J Immunol; 2016 Sep; 197(5):1852-63. PubMed ID: 27439514
[TBL] [Abstract][Full Text] [Related]
17. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4.
Suzuki N; Suzuki S; Duncan GS; Millar DG; Wada T; Mirtsos C; Takada H; Wakeham A; Itie A; Li S; Penninger JM; Wesche H; Ohashi PS; Mak TW; Yeh WC
Nature; 2002 Apr; 416(6882):750-6. PubMed ID: 11923871
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.
Uematsu S; Sato S; Yamamoto M; Hirotani T; Kato H; Takeshita F; Matsuda M; Coban C; Ishii KJ; Kawai T; Takeuchi O; Akira S
J Exp Med; 2005 Mar; 201(6):915-23. PubMed ID: 15767370
[TBL] [Abstract][Full Text] [Related]
19. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways.
Medzhitov R; Preston-Hurlburt P; Kopp E; Stadlen A; Chen C; Ghosh S; Janeway CA
Mol Cell; 1998 Aug; 2(2):253-8. PubMed ID: 9734363
[TBL] [Abstract][Full Text] [Related]
20. TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk.
Brown J; Wang H; Hajishengallis GN; Martin M
J Dent Res; 2011 Apr; 90(4):417-27. PubMed ID: 20940366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
